Guggenheim Issues Positive Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price

Chronological Source Flow
Back

AI Fusion Summary

Guggenheim raises Twist Bioscience’s price target to $55 and maintains a buy rating, while other analysts offer mixed views—TD Cowen reissues a buy, Evercore lifts its target to $52 with an outperform call, Weiss stays sell, and Baird sets $50.
31/03 09:33 defenseworld.net
3 Πηγές
31/03 09:40 defenseworld.net
31/03 10:34 defenseworld.net
Comments
Loading...
0